Corresponding author: Louis Dawson. Correspondence through the editorial office: official@sunpage.org.
Immune-State Models under Reduced Numerical Precision addresses a narrow but consequential interpretive problem: numeric compression changing rare state assignments. The article develops a research agenda through critical comparison of published evidence. The starting source uses a conceptual review proposing immunometabolic set points across immune and tissue compartments. Compression changes the computational representation of a decision. Preserving average prediction quality does not guarantee preservation of rare classes, boundary cases, or uncertainty rankings. Match full- and reduced-precision outputs on identical inputs. Inspect decision-boundary transitions and subgroup losses at a fixed deployment budget, with latency measured on the actual hardware. The proposed comparison concerns cell-state classifiers, quantization, shifted cohorts; it would test whether the specific failure scenario is detected without erasing legitimate uncertainty. An integrated account should preserve the distinction between tissue contexts, clinical endpoints, and mechanistic claims and any stronger downstream decision.
Routine use of an immune-evidence analysis workflow can turn a conditional result into an unconditional-looking recommendation. The specific concern here is compression fidelity, not a general rejection of automation. Consider the possibility of numeric compression changing rare state assignments. This is a proposed stress scenario, not an observed event reported by the cited studies. Its purpose is to expose which evidence contract would be violated even if the final output looked plausible. For tissue contexts, clinical endpoints, and mechanistic claims, the relevant claim must identify its population or artifact class, its time window, and the action it is supposed to support. A failure at any of these levels may persist even after a local technical improvement. The analysis therefore treats published methods as bounded evidence and asks how their limitations interact with this particular decision. An operational analogy is useful only if it keeps those limitations visible.
Compression changes the computational representation of a decision. Preserving average prediction quality does not guarantee preservation of rare classes, boundary cases, or uncertainty rankings. A compressed model should inherit an explicit use contract rather than a vague promise of speed. In this article, the relevant contrast is cell-state classifiers, quantization, shifted cohorts. The proposed counterexample of numeric compression changing rare state assignments puts that contrast under pressure. Match full- and reduced-precision outputs on identical inputs. Inspect decision-boundary transitions and subgroup losses at a fixed deployment budget, with latency measured on the actual hardware. A favorable finding would show that the intended interpretation of shifted cohorts remains defensible when cell-state classifiers is perturbed under the specified conditions. An unfavorable finding should narrow the claim rather than be discarded as an inconvenient case.
The scenario of numeric compression changing rare state assignments is designed to challenge, not illustrate success. It supplies a negative case for compression fidelity that should be judged independently of how fluently the system explains it. The input record should retain enough information to decide which part of that scenario violates the intended contract. That includes the original source type, measurement or artifact status, and the reason the proposed interpretation exceeds its support. The evaluator would compare the system's response with a qualified judgment made without seeing that response. Disagreement should be classified rather than erased by rewriting the prompt. A compressed model should inherit an explicit use contract rather than a vague promise of speed. A useful negative result would show that the interface cannot preserve this distinction under realistic use; a useful positive result would demonstrate preservation on independent cases rather than merely on the example used to develop the rule. The primary source remains relevant through its particular contribution: The set-point framing asks whether durable remission requires changing a coupled metabolic state rather than only lowering an inflammatory marker. That contribution should be retained even if the integrated workflow fails. Conversely, successful integration would not remove the source's limitations or turn a proposed extension into an already observed result. This asymmetric interpretation protects both the literature and the user from an unjustified all-or-nothing verdict.
Calibration separates discrimination from confidence used in clinical escalation (Guo et al. 2017). Discrimination and calibration deserve separate evaluation. A score can order cases well yet systematically overstate its certainty. Aggregate calibration can also hide local miscalibration near the threshold where action changes. An audit should retain predicted probabilities and observed outcomes rather than report only correct classifications, and it should evaluate calibration on data not reused to choose the correction. An implementation should expose this limitation to reviewers of tissue contexts, clinical endpoints, and mechanistic claims. The result and its evidence qualification should remain recoverable even when the interface condenses them into a short report.
Uncertainty can deteriorate under the site and cohort shifts common in biomedicine (Ovadia et al. 2019). Uncertainty is most valuable when a system moves beyond familiar conditions, yet those conditions can also weaken its uncertainty estimates. A warning mechanism must therefore be evaluated under shift rather than assumed to generalize because it works on ordinary held-out data. Different shifts can affect ranking, calibration, and error concentration differently. No single in-distribution curve demonstrates protection against them all. The connection to immune-state models under reduced numerical precision is a constraint on interpretation. It would be inappropriate to borrow the source's methodological authority as direct confirmation of the integrated domain claim.
Selective prediction formalizes abstention when evidence does not support action (Geifman and El-Yaniv 2017). Abstention creates a tradeoff between coverage and residual error. Comparing systems without matching coverage can make one look safer merely because it leaves more work unfinished. Deferred cases also consume human or computational resources. The evaluation should show the risk-coverage relation and account for the fate of excluded cases, rather than treating them as though they have ceased to matter. Within immune-state and tumor evidence synthesis, this distinction is relevant to compression fidelity. The proposed failure scenario is numeric compression changing rare state assignments; its evaluation must preserve the original source's methodological scope.
Feature attribution can guide audit but does not establish biological causality (Lundberg and Lee 2017). Attribution decomposes a model output according to a defined explanatory convention. That decomposition can reveal dependence on suspicious features without establishing why the outcome occurs in the world. Reference choices and feature dependence can affect interpretation. A useful audit should compare explanations with known model behavior and should not transform a feature contribution into a treatment or mechanism claim. An implementation should expose this limitation to reviewers of tissue contexts, clinical endpoints, and mechanistic claims. The result and its evidence qualification should remain recoverable even when the interface condenses them into a short report.
Health-AI governance requires accountability, transparency, inclusion, and protection of autonomy (World Health Organization 2021). Health-AI governance concerns people affected by a system as well as the organization operating it. Transparency without a route to challenge an output is incomplete. Autonomy and inclusion require attention to who can obtain follow-up, who is represented in evaluation, and who bears false alarms. These obligations remain even when an assistance tool is described as advisory rather than decisive. For the comparison involving cell-state classifiers, quantization, shifted cohorts, the source supplies an analytical obligation. The review's proposed application remains a hypothesis, with the deliberately difficult scenario serving as a check on scope inflation.
Replication and transparent workflows are prerequisites for reliable biomedical claims (National Academies 2019). Reproducing a calculation and independently replicating a finding are different achievements. Recoverable data and code allow one to inspect the first; independent observations and design choices inform the second. A review should avoid calling several reanalyses of one dataset separate replications. Clear reporting of analysis changes also makes a failed replication informative instead of allowing it to disappear as an implementation dispute. This is methodological support for examining compression fidelity, not a claim that the source studied immune-state and tumor evidence synthesis. A separate application-specific test is required at the interface described in this review.
FAIR principles support reusable cohorts, signals, and analysis metadata (Wilkinson et al. 2016). Reusable evidence needs more than a downloadable file. Identifiers, metadata, provenance, and meaningful access conditions help another researcher determine what an artifact contains and whether it can answer a new question. Reuse does not mean universal permission or universal scientific comparability. The information needed to judge those boundaries should travel with the artifact rather than remain in private workflow knowledge. Within immune-state and tumor evidence synthesis, this distinction is relevant to compression fidelity. The proposed failure scenario is numeric compression changing rare state assignments; its evaluation must preserve the original source's methodological scope.
Causal inference requires a clearly specified intervention, time order, and exchangeability assumptions (Hernán and Robins 2020). A prediction can be accurate without identifying what an intervention would change. A useful causal analysis begins by defining the hypothetical comparison, eligibility, and time zero. Its assumptions concern the process generating exposure and observation, not merely the flexibility of a fitted model. In this review, causal vocabulary is appropriate only when that comparison can be specified and defended. An implementation should expose this limitation to reviewers of tissue contexts, clinical endpoints, and mechanistic claims. The result and its evidence qualification should remain recoverable even when the interface condenses them into a short report.
Epidemiologic design makes confounding, selection, and measurement error part of interpretation (Rothman, Greenland, and Lash 2008). Confounding, selection, and measurement error are distinct problems and need not move an estimate in the same direction. An analysis should describe them before deciding which adjustment is adequate. A larger dataset can reduce random error while leaving systematic error almost untouched. Precision should therefore be interpreted alongside the quality of the design and the eligibility of its population. Within immune-state and tumor evidence synthesis, this distinction is relevant to compression fidelity. The proposed failure scenario is numeric compression changing rare state assignments; its evaluation must preserve the original source's methodological scope.
False-discovery control is central when many molecular features are screened (Benjamini and Hochberg 1995). Multiplicity arises from the family of questions actually searched. Controlling false discoveries within a named family does not automatically cover later tissue filters, alternative endpoints, or narrative choices. The proposed audit should retain exploratory branches so the family is visible. Independent confirmation then addresses a different question from whether a discovery threshold was correctly applied during screening. Within immune-state and tumor evidence synthesis, this distinction is relevant to compression fidelity. The proposed failure scenario is numeric compression changing rare state assignments; its evaluation must preserve the original source's methodological scope.
The relevant question in Resetting Immunometabolic Set Points in Autoimmune Disease is why autoimmune activity can persist or recur when conventional inflammation suppression does not durably change underlying cellular and tissue states (Xiao Yu et al. 2026e). Its methodological basis is a conceptual review proposing immunometabolic set points across immune and tissue compartments. The accessible evidence is specific: the review integrates cellular metabolism, nutrient/oxygen conditions, mitochondrial stress, and stromal metabolites as candidate mechanisms of persistence. The set-point framing asks whether durable remission requires changing a coupled metabolic state rather than only lowering an inflammatory marker. A unifying set point is a hypothesis, not an already validated clinical measurement or an established therapeutic protocol. The source supplies one part of the comparison involving cell-state classifiers, quantization, shifted cohorts. Its evidence should retain its original unit and scope; the present synthesis proposes a connection without claiming that the paper directly tested this integrated workflow.
A useful boundary case is supplied by Machine Learning–Based Prediction of Early Visual Field Nonrecovery after Endoscopic Surgery for Nonfunctioning Pituitary Adenomas with Clinically Accessible Biomarkers: A Dual-Center Study, concerned with whether accessible preoperative biomarkers can predict early visual-field nonrecovery after surgery for nonfunctioning pituitary adenomas (Sunjiang Liu et al. 2026). Its methodological basis is a retrospective dual-center design with LASSO selection, multivariable logistic modeling, and a nomogram; training comprised 268 patients and validation 100. The accessible evidence is specific: the study includes 368 patients, defines early improvement at postoperative day seven, and reports age, vertical tumor diameter, and fasting glucose as predictors; reported C-indices are approximately 0.747 and 0.753. It develops an accessible early-risk tool with geographically separate validation instead of relying solely on model fit in development data. Day-seven nonrecovery is not permanent visual loss; retrospective selection, limited validation events, and unmeasured care differences constrain interpretation. The contribution becomes relevant to compression fidelity when the workflow moves from cell-state classifiers to shifted cohorts. That transition is the review's proposed analytical focus, not a new result attributed to the source.
AutoCrit: A Meta-Reasoning Framework for Self-Critique and Iterative Error Correction in LLM Chains-of-Thought asks whether structured self-critique can interrupt error propagation in language-model reasoning chains (Yinghao. “AutoCrit: A Meta-Reasoning Framework for Self-Critique Sang 2025). Its methodological basis is a reasoning agent, critique agent, and execution monitor provide iterative stepwise feedback and correction. The accessible evidence is specific: the abstract describes GSM8K, CSQA2, and ALFWorld evaluations, reported improvements over chain-of-thought baselines, and a fixed-point analysis of the correction process. It organizes critique as a monitored reasoning process rather than a single request to reconsider an answer. Shared model biases can correlate critic and reasoner errors, while extra iterations increase cost; benchmark gains do not establish clinical factuality. This source enters the present review as a methodological comparison for evidence processing, not as evidence about disease biology, patient outcomes, or clinical efficacy. The transferable question is whether cell-state classifiers remains correctly interpreted after a computational choice involving shifted cohorts. Its task-specific validation cannot be borrowed to validate the clinical claim.
The sources should be compared through the roles they play, not merged into a single performance claim. Resetting Immunometabolic Set Points in Autoimmune Disease addresses why autoimmune activity can persist or recur when conventional inflammation suppression does not durably change underlying cellular and tissue states (Xiao Yu et al. 2026e). By contrast, AutoCrit: A Meta-Reasoning Framework for Self-Critique and Iterative Error Correction in LLM Chains-of-Thought addresses whether structured self-critique can interrupt error propagation in language-model reasoning chains (Yinghao. “AutoCrit: A Meta-Reasoning Framework for Self-Critique Sang 2025). That difference matters for compression fidelity: the evidence concerning cell-state classifiers is not automatically evidence concerning shifted cohorts. A successful software operation, a plausible mechanistic account, and a validated outcome are different achievements. Their integration may improve traceability, but it cannot create an unmeasured link. A coherent review should identify where the sources complement one another and where their scopes remain incompatible. Here the proposed failure scenario is numeric compression changing rare state assignments. The analytical value of that scenario is that it can occur without requiring any cited paper to be wrong: an otherwise valid local finding can be misused at a later interface. Preventing that misuse requires evidence about the interface itself, not simply a larger collection of local results.
Match full- and reduced-precision outputs on identical inputs. Inspect decision-boundary transitions and subgroup losses at a fixed deployment budget, with latency measured on the actual hardware. This would operationalize the concern with compression fidelity rather than assume it has been resolved by one successful output. These procedures are proposed, not completed. The case set would include the scenario of numeric compression changing rare state assignments, with its validity judged independently of the system's response. The relevant comparison axes are cell-state classifiers, quantization, shifted cohorts.
A stress-focused protocol would match information access and total operating budget while varying the focal constraint. It would include ordinary cases, rare severe cases, and deliberately shifted conditions. Intermediate outputs would expose whether a gain comes from better behavior, omitted work, or hidden assistance. The evaluation would retain recovery costs and failed cases; an attractive average would not override a documented loss at a consequential boundary.
For the immune review, proposed mechanisms should be tested in their stated compartments and disease settings. Spatial association, state annotation, and intervention response would be judged separately. A useful result could expose a missing bridge in the integrated account. It would not need to confirm every part of the preferred narrative to improve scientific understanding.
The cited sources still have design-specific limits even where their abstracts and methods are accessible. This review is a bounded conceptual synthesis rather than a systematic review with an exhaustive search protocol. It cannot establish the effectiveness of the proposed integrated workflow. Its specific contribution is to articulate how compression fidelity changes the interpretation of cell-state classifiers, quantization, shifted cohorts. Technical sources support computational comparisons only; they do not validate biological mechanisms or patient benefit. Reviews and correspondence retain their publication roles and are not counted as new experiments. Proposed stress cases are illustrative, not observed failures attributed to the papers. Future work should therefore test the weakest inference described here, preserve contrary results, and disclose the cost of checking rather than treating additional automation as intrinsically beneficial.
The most valuable next result would be a discriminating test of compression fidelity, including a realistic way for the preferred approach to fail. Match full- and reduced-precision outputs on identical inputs. Inspect decision-boundary transitions and subgroup losses at a fixed deployment budget, with latency measured on the actual hardware. The central methodological contribution is specific: The set-point framing asks whether durable remission requires changing a coupled metabolic state rather than only lowering an inflammatory marker. Extending it to shifted cohorts is an additional hypothesis, not a result supplied by the citation. The cited studies provide useful but different forms of support. Their integration should increase traceability and expose missing links, leaving clinical, mechanistic, and operational claims at the strength justified by their own evidence.
1. Yu, Xiao, et al. “Resetting Immunometabolic Set Points in Autoimmune Disease.” Journal of Translational Autoimmunity, vol. 13, 2026, https://doi.org/10.1016/j.jtauto.2026.100391.
2. Liu, Sunjiang, et al. “Machine Learning–Based Prediction of Early Visual Field Nonrecovery after Endoscopic Surgery for Nonfunctioning Pituitary Adenomas with Clinically Accessible Biomarkers: A Dual-Center Study.” International Journal of Clinical Practice, vol. 2026, no. 1, 2026, https://doi.org/10.1155/ijcp/2504255.
3. Sang, Yinghao. “AutoCrit: A Meta-Reasoning Framework for Self-Critique and Iterative Error Correction in LLM Chains-of-Thought.” 2025 6th International Conference on Machine Learning and Computer Application (ICMLCA), IEEE, 2025, pp. 1177–80, https://doi.org/10.1109/icmlca66850.2025.11336788.
4. Guo, Chuan, et al. “On Calibration of Modern Neural Networks.” Proceedings of the 34th International Conference on Machine Learning, 2017, pp. 1321–30.
5. Ovadia, Yaniv, et al. “Can You Trust Your Model’s Uncertainty? Evaluating Predictive Uncertainty under Dataset Shift.” Advances in Neural Information Processing Systems, vol. 32, 2019.
6. Geifman, Yonatan, and Ran El-Yaniv. “Selective Classification for Deep Neural Networks.” Advances in Neural Information Processing Systems, vol. 30, 2017.
7. Lundberg, Scott M., and Su-In Lee. “A Unified Approach to Interpreting Model Predictions.” Advances in Neural Information Processing Systems, vol. 30, 2017.
8. World Health Organization. Ethics and Governance of Artificial Intelligence for Health. World Health Organization, 2021.
9. National Academies of Sciences, Engineering, and Medicine. Reproducibility and Replicability in Science. National Academies Press, 2019.
10. Wilkinson, Mark D., et al. “The FAIR Guiding Principles for Scientific Data Management and Stewardship.” Scientific Data, vol. 3, 2016, article 160018.
11. Hernán, Miguel A., and James M. Robins. Causal Inference: What If. Chapman & Hall/CRC, 2020.
12. Rothman, Kenneth J., Sander Greenland, and Timothy L. Lash. Modern Epidemiology. 3rd ed., Lippincott Williams & Wilkins, 2008.
13. Benjamini, Yoav, and Yosef Hochberg. “Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.” Journal of the Royal Statistical Society: Series B, vol. 57, no. 1, 1995, pp. 289–300.